Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
27 Cards in this Set
- Front
- Back
corticosteroids are produced where
|
adrenal cortex
|
|
two major physiologic and pharmacologic groups of corticosteroids
|
glucocorticoids- effects on intermediary metabolism, immune responses, inflammation
mineralocorticoids- regulate sodium and potassium reabsorption in collecting tubules of the kidney |
|
MOA of glucocorticoids
|
enter cell, bind to cytosolic receptors that transport the steroid into the nucleus
-steroid-receptor complex alters gene expression by binding to glucocorticoid response elements (GREs) -tissue specific responses to steroids due to presence in each tissue of different protein regulators that control interaction between hormone-receptor complex and particular response elements |
|
metabolic effects of glucocorticoids
|
-stimulate gluconeogenesis
- blood glucose rises - muscle protein is catabolized - insulin secretion is stimulated - lipolysis and lipogenesis are stimulated- net increase of fat deposition in certain areas (face, shoulders, back) |
|
catabolic effects of glucocorticoids
|
- muscle protein catabolism
- lymphoid and connective tissue, fat, skin undergo wasting under influence of high concentration of steroids - catabolic effects on bone= osteoporosis - growth inhibition in children |
|
immunosuppressive effects of glucocorticoids
|
-inhibit cell mediated immunologic functions-esp those dependent on lymphocytes
- actively lymphotoxic and are important in treatment of hematologic cancers -do not interfere with development of normal acquired immunity - delay rejection reactions in pt with organ transplants |
|
anti-inflammatory effects of glucocorticoids
|
- dramatic effect on distribution and function of leukocytes
- increase neutrophils and decrease lymphocytes, eosinophils, basophils, and monocytes - migration of leukocytes inhibited |
|
biomechanical explanation of anti-inflammatory effects of glucocorticoids
|
-induced synthesis of an inhibitor of phospholipase A2, decreased mRNA for cyclooxygenase-2 (COX-2), decreases in IL-2 and IL-3, decreases in platelet activating factor (PAF)
|
|
Other effects of glucocorticoids
|
-required for normal renal excretion of water
- effects on CNS-behavioral changes - large doses stimulate gastric acid secretion and decrease resistance to ulcer formation |
|
major natural glucocorticoid and its regulation
|
cortisol
- regulated by ACTH and varies during the day |
|
circadian rhythm of cortisol
|
peak levels in the morning and trough occurs around midnight
|
|
form of cortisol in plasma
|
95% bound to corticosteroid-binding globulin
|
|
route of cortisol absorption/excretion
|
given orally, absorbed well from the GI tract
- cleared by the liver -short duration of action -diffuses poorly across normal skin but is readily absorbed across inflamed skin/mucous membranes |
|
secondary effect of cortisol
|
small salt-retaining mineralocorticoid effect
- important cause of HTN in patients with a cortisol-secreting adrenal tumor or a pituitary ACTH-secreting tumor (Cushings) |
|
synthetic glucocorticoids
|
prednisone and active metabolite (prednisolone), dexamethasone, triamcinolone
|
|
properties of synthetic vs, cortisol
|
longer half-life and duration of action, reduced salt-retaining effect, better penetration of lipid barriers for topical activity
|
|
glucocorticoids that penetrate the airway mucosa but have very short half-lives after they enter, reducing systemic effects and toxicity
|
beclomethasone and budesonide
|
|
Clinical Uses of glucocorticoids
|
adrenal disorders- preserve life in patients with chronic adrenal cortical insufficiency (Addison's disease)
- necessary in acute adrenal insufficiency associated with life-threatening shock, infection, trauma - used in CAH, where synthesis of abnormal forms of corticosteroids are stimulated by ACTH - giving potent synthetic suppresses ACTH secretion enough to reduce synthesis of abnormal |
|
Clinical use of nonadrenal disorders
|
inflammatory or immunological (asthma, organ transplant rejection, collagen diseases, rheumatic disorders)
- treatment of hematopoietic cancers, neuro disorders, chemo-induced vomiting, hypercalcemia, mountain sickness |
|
blucocorticoid with low degree of protein binding
|
pregnant women in premature labor to hasten maturation of fetal lungs
|
|
toxicity of glucocorticoids
|
-some life threatening- growth inhibition, diabetes, muscle wasting, osteoporosis, salt retention, psychosis
- minimize these by alternate-day therapy - doses need to be tapered over several months to allow recovery of normal adrenal function |
|
Major mineralocorticoid
|
-aldosterone--> regulates blood pressure and blood volume
|
|
secretion of aldosterone regulated by
|
ACTH and renin-angiotensin system
|
|
other mineralocorticoids
|
deoxycorticosterone, naturally occurring precursor of aldosterone
- fludrocortisone- glucocorticoid activity- long duration of action so favored for replacement therapy after adrenalectomy |
|
Receptor Antagonists of corticosteroids
|
spironolactone and eplerenone- antagonists of aldosterone at its receptor- diuretics
|
|
Mifepristone (RU-486)
|
competitive inhibitor of glucocorticoid receptors as well as progesterone receptors and used in Cushing's
|
|
synthesis inhibitors
|
-ketoconazole- antifungal that inhibits the cytochrome P450 enzymes needed for synthesis of all steroids- used when steroids are bad- adrenal carcinoma, hirsutism, breast and prostate cancer)
-aminoglutethimide- blocks conersion of cholesterol to pregnenolone- inhibits synthesis of all hormonally active steroids- in conjunction w/ other drugs for treatment of steroid-producing adrenocortical cancer - metyrapone- inhibits normal synthesis of cortisol but not precursors- diagnostic tests of adrenal function |